Intuitive Surgical/ISRG
US$398.82
0.94%-
1D1W1MYTD1YMAX
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
Ticker
ISRG
Sector
Healthcare
Trading on
NASDAQ
Industry
Medical Equipment & Supplies
CEO
Gary Guthart
Employees
13,676
Headquarters
Sunnyvale, United States
Website
www.intuitivesurgical.com
ISRG Metrics
BasicAdvanced
US$141B
Market cap
71.97
P/E ratio
US$5.54
EPS
1.39
Beta
-
Dividend rate
Price and volume
Market cap
US$141B
Beta
1.38884
52-week high
US$403.76
52-week low
US$254.85
Average daily volume
1.4M
Financial strength
Current ratio
5.551
Quick ratio
4.606
Enterprise value to free cash flow
100.128
Management effectiveness
Return on assets (TTM)
13.88%
Return on equity (TTM)
15.79%
Return on investment (TTM)
15.39%
Valuation
Price to earnings (TTM)
71.968
Price to revenue (TTM)
19.33
Price to book
10.131
Price to tangible book (TTM)
10.417
Price to free cash flow (TTM)
237.435
Growth
Revenue change (TTM)
13.81%
Earnings per share change (TTM)
51.7%
3-year revenue growth
17.8%
3-year earnings per share growth
19.63%
What the Analysts think about ISRG
Analyst Ratings
Majority rating from 31 analysts.
Price Targets
Average projection from 24 analysts.
High US$475.00
Low US$375.00
US$398.82
Current price
US$424.34
Average price target
ISRG Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
US$1.9B
-1.96%
Net income
US$545M
-10.11%
Profit margin
28.82%
-8.3%
ISRG Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
US$1.42
US$1.46
US$1.60
US$1.50
-
Expected
US$1.33
US$1.41
US$1.48
US$1.41
US$1.54
Surprise
7.09%
3.38%
7.82%
6.53%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Intuitive Surgical stock?
Intuitive Surgical (ISRG) has a market cap of $141B as of May 20, 2024.
What is the P/E ratio for Intuitive Surgical stock?
The price to earnings (P/E) ratio for Intuitive Surgical (ISRG) stock is 71.97 as of May 20, 2024.
Does Intuitive Surgical stock pay dividends?
No, Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders as of May 20, 2024.
When is the next Intuitive Surgical dividend payment date?
Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders.
What is the beta indicator for Intuitive Surgical?
Intuitive Surgical (ISRG) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
What is the Intuitive Surgical stock price target?
The target price for Intuitive Surgical (ISRG) stock is $424.34, which is 6.4% above the current price of $398.82. This is an average based on projections from 24 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Intuitive Surgical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.